Dhampur Bio Organics quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	919	784	+17.2%
EBITDA	8.9	1.4	+547.8%
EBITDA margin	1.0%	0.2%	+0.8 pts
Profit before tax	−18.3	−33.0	—
Net profit	36.8	−22.0	—
EPS	₹5.59	−₹3.31	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023

Expenses
	919	774	751	825	784	703	719	634	638	595	425	666
	1.2	7.8	9.0	13.5	1.6	1.1	0.4	1.4	0.8	5.0	15.9	0.6
	920	781	760	838	785	704	719	635	639	600	441	666
	65.1	752	597	19.9	106	745	536	1.9	79.6	859	533	4.6
	81.2	1.0	0.5	20.1	19.6	20.7	10.3	0.4	0.2	0.3	0.5	0.5
	286	−421	−262	444	320	−502	−197	401	289	−579	−353	446
	23.6	32.0	29.6	27.1	24.8	27.2	27.3	24.3	21.9	23.5	29.1	20.7
	15.6	16.5	10.6	14.3	21.6	20.2	10.1	15.8	21.1	17.6	5.7	8.8
	12.9	14.7	15.3	14.6	14.3	16.0	14.7	11.3	11.9	14.3	13.6	10.5
	454	315	343	321	312	317	326	215	215	209	220	175
	938	710	735	862	818	643	728	670	638	545	448	666
	8.9	94.9	42.6	−8.1	1.4	95.7	15.9	−9.7	32.9	81.2	−4.4	19.2
	−3.9	80.2	27.3	−22.6	−12.9	79.7	1.3	−21.1	21.1	66.9	−18.1	8.7
Profit
	−18.3	71.6	25.7	−23.4	−33.0	60.6	−8.4	−35.4	0.7	54.4	−7.8	0.5
	0.0	0.0	0.0	0.0	0.0	0.0	−1.8	0.0	0.0	0.0	0.0	0.0
	−18.3	71.6	25.7	−23.4	−33.0	60.6	−10.1	−35.4	0.7	54.4	−7.8	0.5
	0.1	6.0	−0.0	0.5	0.0	4.3	−0.0	−0.3	0.3	9.1	−1.1	0.2
	−4.6	19.3	8.8	−7.9	−11.0	11.5	−3.2	−11.8	0.3	5.9	−1.1	0.2
	−4.5	25.3	8.8	−7.4	−11.0	15.8	−3.3	−12.1	0.6	15.0	−2.2	0.4
	36.8	46.3	16.9	−16.0	−22.0	44.8	−6.9	−23.4	0.1	39.4	−5.6	0.1
	−13.8	46.3	16.9	−16.0	−22.0	44.8	−6.9	−23.4	0.1	39.4	−5.6	0.1
	50.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−0.0	3.0	−1.3	1.0	−0.1	1.3	0.6	0.1	0.1	−0.8	−0.0	0.4
	36.8	49.3	15.6	−15.0	−22.1	46.1	−6.3	−23.3	0.2	38.6	−5.7	0.5
	36.8	46.3	16.9	−16.0	−22.0	46.1	−6.9	−23.3	0.1	39.4	−5.6	0.1
Per share
	₹5.59	₹7.01	₹2.56	−₹2.41	−₹3.31	₹6.75	−₹1.03	−₹3.52	₹0.02	₹5.94	−₹0.85	₹0.01
	₹5.56	₹6.98	₹2.55	−₹2.41	−₹3.31	₹6.75	−₹1.03	−₹3.52	₹0.02	₹5.94	−₹0.85	₹0.01
Continuing & discontinued operations
	62.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other comprehensive income — detail
	−0.0	3.0	−1.3	1.0	−0.1	1.3	—	—	—	—	—	—
	—	2.2	−2.2	—	—	1.8	—	—	—	−1.2	—	—
	0.0	0.6	−0.6	—	0.0	0.4	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	0.0	0.0	−0.3	—	—
	−0.0	1.4	0.3	1.0	−0.1	0.0	0.6	0.1	0.1	0.1	−0.0	0.4
	36.8	49.3	15.6	−15.0	−22.1	—	−6.3	−23.3	0.2	38.6	−5.7	0.5
Per share — as-filed variants
	−₹2.09	₹7.01	₹2.56	−₹2.41	−₹3.31	₹6.75	−₹1.03	−₹3.52	₹0.02	₹5.94	−₹0.85	₹0.01
	−₹2.08	₹6.98	₹2.55	−₹2.41	−₹3.31	₹6.75	−₹1.03	−₹3.52	₹0.02	₹5.94	−₹0.85	₹0.01
	₹7.68	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
	₹7.64	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	486	441	415	340	338	439	369	230	270	314	244	215
	53.0%	57.1%	55.2%	41.3%	43.2%	62.5%	51.3%	36.3%	42.3%	52.8%	57.6%	32.3%
Adjusted (ex-exceptional items) — derived
	−18.3	71.6	25.7	−23.4	−33.0	60.6	−8.4	−35.4	0.7	54.4	−7.8	0.5
	0.0	0.0	0.0	0.0	0.0	0.0	−1.8	0.0	0.0	0.0	0.0	0.0
	36.8	46.3	16.9	−16.0	−22.0	44.8	−5.7	−23.4	0.1	39.4	−5.6	0.1
	₹5.59	₹7.01	₹2.56	−₹2.41	−₹3.31	₹6.75	−₹0.85	−₹3.52	₹0.02	₹5.94	−₹0.85	₹0.01

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

DBOL₹126.23

Dhampur Bio Organics Limited

· FMCG & Retail

Annual Quarterly₹ CrorePeersMAGADSUGAR ZUARIIND DWARKESH DHAMPURSUG UGARSUGAR UTTAMSUGAR MAWANASUG DCMSRINDMcap ₹838 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	665.6	424.8	594.6	637.8	633.6	718.8	702.7	783.7	824.9	751.3	773.6	918.6
Other Income	0.6	15.9	5.0	0.8	1.4	0.4	1.1	1.6	13.5	9.0	7.8	1.2
Total Income	666.2	440.6	599.7	638.6	635.0	719.3	703.8	785.3	838.4	760.2	781.4	919.8
Expenses
+ Cost of Materials Consumed	4.6	532.9	859.0	79.6	1.9	536.2	744.5	105.6	19.9	597.3	752.3	65.1
+ Purchases of Stock-in-Trade	0.5	0.5	0.3	0.2	0.4	10.3	20.7	19.6	20.1	0.5	1.0	81.2
+ Changes in Inventories	445.6	-353.2	-578.7	288.5	401.5	-196.7	-502.0	320.1	444.4	-261.5	-421.1	285.9
+ Employee Benefit Expense	20.7	29.1	23.5	21.9	24.3	27.3	27.2	24.8	27.1	29.6	32.0	23.6
+ Finance Costs	8.8	5.7	17.6	21.1	15.8	10.1	20.2	21.6	14.3	10.6	16.5	15.6
+ Depreciation & Amortisation	10.5	13.6	14.3	11.9	11.3	14.7	16.0	14.3	14.6	15.3	14.7	12.9
+ Other Expenses	175.0	219.9	209.4	214.7	215.2	325.9	316.6	312.2	321.4	342.7	314.5	453.9
Total Expenses	665.7	448.5	545.3	637.9	670.4	727.6	643.2	818.2	861.8	734.5	709.8	938.1
EBITDA	19.2	-4.4	81.2	32.9	-9.7	15.9	95.7	1.4	-8.1	42.6	94.9	8.9
EBIT	8.7	-18.1	66.9	21.1	-21.1	1.3	79.7	-12.9	-22.6	27.3	80.2	-3.9
Profit
PBT before Exceptional Items	0.5	-7.8	54.4	0.7	-35.4	-8.4	60.6	-33.0	-23.4	25.7	71.6	-18.3
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	-1.8	0.0	0.0	0.0	0.0	0.0	0.0
Pretax Income	0.5	-7.8	54.4	0.7	-35.4	-10.1	60.6	-33.0	-23.4	25.7	71.6	-18.3
+ Current Tax	0.2	-1.1	9.1	0.3	-0.3	-0.0	4.3	0.0	0.5	-0.0	6.0	0.1
+ Deferred Tax	0.2	-1.1	5.9	0.3	-11.8	-3.2	11.5	-11.0	-7.9	8.8	19.3	-4.6
Tax Expense	0.4	-2.2	15.0	0.6	-12.1	-3.3	15.8	-11.0	-7.4	8.8	25.3	-4.5
Net Income	0.1	-5.6	39.4	0.1	-23.4	-6.9	44.8	-22.0	-16.0	16.9	46.3	36.8
+ Net Income — Continuing Ops	0.1	-5.6	39.4	0.1	-23.4	-6.9	44.8	-22.0	-16.0	16.9	46.3	-13.8
+ Net Income — Discontinued Ops	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5
+ Other Comprehensive Income	0.4	-0.0	-0.8	0.1	0.1	0.6	1.3	-0.1	1.0	-1.3	3.0	-0.0
Total Comprehensive Income	0.5	-5.7	38.6	0.2	-23.3	-6.3	46.1	-22.1	-15.0	15.6	49.3	36.8
Net Income to Common	0.1	-5.6	39.4	0.1	-23.3	-6.9	46.1	-22.0	-16.0	16.9	46.3	36.8
Per Share
Basic EPS	0.01	-0.85	5.94	0.02	-3.52	-1.03	6.75	-3.31	-2.41	2.56	7.01	5.59
Diluted EPS	0.01	-0.85	5.94	0.02	-3.52	-1.03	6.75	-3.31	-2.41	2.55	6.98	5.56
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.2
+ Tax — Discontinued Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	1.3	-0.1	1.0	-1.3	3.0	-0.0
+ Items NOT to be Reclassified to P&L	—	—	-1.2	—	—	—	1.8	—	—	-2.2	2.2	—
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.4	0.0	—	-0.6	0.6	0.0
+ Tax on Items NOT to be Reclassified — alt tag	—	—	-0.3	0.0	0.0	0.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	0.4	-0.0	0.1	0.1	0.1	0.6	0.0	-0.1	1.0	0.3	1.4	-0.0
Comprehensive Income — Owners of Parent	0.5	-5.7	38.6	0.2	-23.3	-6.3	—	-22.1	-15.0	15.6	49.3	36.8
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.01	-0.85	5.94	0.02	-3.52	-1.03	6.75	-3.31	-2.41	2.56	7.01	-2.09
Diluted EPS — Continuing Operations	0.01	-0.85	5.94	0.02	-3.52	-1.03	6.75	-3.31	-2.41	2.55	6.98	-2.08
Basic EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.68
Diluted EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.64
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	214.8	244.5	314.1	269.6	229.8	369.1	439.5	338.3	340.4	414.9	441.4	486.4
Gross Margin %	32.27	57.56	52.82	42.26	36.27	51.34	62.54	43.17	41.27	55.23	57.06	52.95
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	0.5	-7.8	54.4	0.7	-35.4	-8.4	60.6	-33.0	-23.4	25.7	71.6	-18.3
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	-1.8	0.0	0.0	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	0.1	-5.6	39.4	0.1	-23.4	-5.7	44.8	-22.0	-16.0	16.9	46.3	36.8
EPS Adj	0.01	-0.85	5.94	0.02	-3.52	-0.85	6.75	-3.31	-2.41	2.56	7.01	5.59
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	66.4	66.4	66.4	66.4	66.4	66.4	6.6	66.4	66.4	66.4	66.4	66.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Dhampur Bio Organics quarterly results

Dhampur Bio Organics (NSE: DBOL) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹36.8 crore, against a loss of ₹22 crore in Q1 FY26 and down 20.5% from ₹46.3 crore in Q4 FY26. Revenue from operations was ₹919 crore, up 17.2% year on year and up 18.7% from the previous quarter.

Q2 FY26 results (a year earlier): 13 November 2025
Q1 FY27 results (the latest): 14 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹36.8 Crloss ₹22 Cr in Q1 FY26−20.5% vs Q4 FY26
Q1 FY27 revenue: ₹919 Cr+17.2% vs Q1 FY26+18.7% vs Q4 FY26
Q1 FY27 operating margin: −0.4%+1.2 pts vs Q1 FY26−10.8 pts vs Q4 FY26
Q2 FY26 net loss (a year earlier): −₹16 CrRevenue ₹825 Cr
Q1 FY27 EPS (basic): ₹5.59

Questions

When will Dhampur Bio Organics announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 13 November 2025.

What was Dhampur Bio Organics' net profit in FY26?

Consolidated net profit was ₹25.2 crore in FY26 (April 2025–March 2026), up 50.6% from ₹16.7 crore in FY25. It was ₹46.5 crore in FY24 and ₹111 crore in FY23: down 77.3% over three years, an average fall of 39.0% a year.

What was Dhampur Bio Organics' revenue in FY26?

Revenue from operations was ₹3,133 crore in FY26 (April 2025–March 2026), up 16.4% from ₹2,693 crore in FY25. It was ₹2,394 crore in FY24 and ₹2,654 crore in FY23: up 18.0% over three years, 5.7% a year on average.

What will Dhampur Bio Organics' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net loss was ₹16 crore and revenue from operations ₹825 crore. The latest quarter, Q1 FY27, had a net profit of ₹36.8 crore and revenue of ₹919 crore.

What were Dhampur Bio Organics' Q1 FY27 results?

Consolidated net profit was ₹36.8 crore, against a loss of ₹22 crore in Q1 FY26 and down 20.5% from ₹46.3 crore in Q4 FY26. Revenue from operations was ₹919 crore, up 17.2% year on year and up 18.7% from the previous quarter.

How has Dhampur Bio Organics' profit changed over the last four quarters?

Net profit by quarter: a loss of ₹16 crore in Q2 FY26, a profit of ₹16.9 crore in Q3 FY26, a profit of ₹46.3 crore in Q4 FY26 and a profit of ₹36.8 crore in Q1 FY27. That is a combined profit of ₹84 crore over the four quarters. Revenue from operations: ₹825 crore, ₹751 crore, ₹774 crore and ₹919 crore.

Where do these Dhampur Bio Organics figures come from?

From Dhampur Bio Organics' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.